Sign Out
Metabolism/Transport Effects Substrate of CYP2C19 (minor), CYP2C9 (minor); Note: Assignment of major/Minor substrate status based on clinically relevant drug interaction potential; Inhibit CYP2C9 (weak).
Avoid Concomitant Use: Avoid concomitant use of Ibuprofen with any of the following: Floctafenine; Ketorolac (Nasal); Ketorolac (Systemic); NSAIDs (COX-2 Inhibitor); Omacetaxine.
